Many factors can affect lymphoma outlook, including the type, stage and spread of cancer, and a person's age and overall health. Read about lymphoma survival here.

Treatments for non-Hodgkin lymphoma, a cancer of white blood cells, include chemotherapy, immunotherapy, radiation therapy, and stem cell transplants, with the specific approach depending on the ...

The study involves testing epcoritamab, administered subcutaneously, in combination with oral and intravenous anti-neoplastic agents. These include drugs like lenalidomide, ibrutinib, and polatuzumab ...

Results from the Phase III KEYNOTE-689 trial show that adding perioperative Keytruda (pembrolizumab) to standard-of-care ...

Blood cancer, which originates from irregular blood cell generation within the bone marrow, represents a serious health ...

The first prediction tool of its kind for early-stage classic Hodgkin lymphoma provides estimates using continuous variables capturing nonlinear context.

Andrew Evens, DO, MBA, MSc, discusses a modern way of stratifying risk in patients with early-stage Hodgkin lymphoma.

Clinical outcomes of a new local CD19 CAR-T cell therapy for patients with relapsed or refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma in Malaysia S. Fadilah Abdul Wahid ...

Young patients with advanced Hodgkin's lymphoma, a cancer of the lymphatic system, now have a better chance of having their ...

The hemoglobin, albumin, lymphocyte, and platelet (HALP) score can help to guide treatment decisions in patients living with ...

Non-hodgkin lymphoma articles from across Nature Portfolio Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally ...

Older patients with small cell lung cancer and significant weight loss were more likely to experience dose interruptions than ...